Potent T Cell Responses Induced by a Recombinant Adenovirus Vaccine Vector Based on Rare Human Serotype 28 That Are Not Predicted by In Vitro Cytokine Secretion Patterns

被引：0
|
作者：
Kahl, Christoph A. [1 ]
Bonnell, Jessica [1 ]
Hiriyanna, Suja [1 ]
Fultz, Megan [1 ]
Hoffman, Cassandra [1 ]
Chen, Ping [1 ]
King, C. Richter [1 ]
Gall, Jason [1 ]
机构：
[1] GenVec Inc, Gaithersburg, MD USA
来源：
MOLECULAR THERAPY | 2009年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：S367 / S367
页数：1
相关论文
共 20 条
  • [1] Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28
    Kahl, Christoph A.
    Bonnell, Jessica
    Hiriyanna, Suja
    Fultz, Megan
    Nyberg-Hoffman, Cassandra
    Chen, Ping
    King, C. Richter
    Gall, Jason G. D.
    VACCINE, 2010, 28 (35) : 5691 - 5702
  • [2] Potent T cell Responses Induced by Single DNA Vaccine Boosted with Recombinant Vaccinia Vaccine
    Lianxing Liu
    Chao Qiu
    Yang Huang
    Jianqing Xu
    Yiming Shao
    Virologica Sinica, 2013, (02) : 109 - 115
  • [3] Potent T cell Responses Induced by Single DNA Vaccine Boosted with Recombinant Vaccinia Vaccine
    Lianxing Liu
    Chao Qiu
    Yang Huang
    Jianqing Xu
    Yiming Shao
    Virologica Sinica, 2013, 28 (02) : 109 - 115
  • [4] Recombinant adenovirus vector vaccine induces stronger cytotoxic T-cell responses than recombinant vaccinia virus vector, plasmid DNA, or a combination of these
    Maeda, K
    West, K
    Hayasaka, D
    Ennis, FA
    Terajima, M
    VIRAL IMMUNOLOGY, 2005, 18 (04) : 657 - 667
  • [5] An in vitro model of vaccine induced human Leishmania specific T cell responses.
    Russo, D
    Chakrabarti, P
    Burns, J
    FASEB JOURNAL, 1999, 13 (04): : A636 - A636
  • [6] A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro
    Tapia-Calle, Gabriela
    Born, Philip A.
    Koutsoumpli, Georgia
    Gonzalez-Rodriguez, Martin Ignacio
    Hinrichs, Wouter L. J.
    Huckriede, Anke L. W.
    VACCINES, 2019, 7 (04)
  • [7] Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates
    Bolton, Diane L.
    Santra, Sampa
    Swett-Tapia, Cindy
    Custers, Jerome
    Song, Kaimei
    Balachandran, Harikrishnan
    Mach, Linh
    Naim, Hussein
    Kozlowski, Pamela A.
    Lifton, Michelle
    Goudsmit, Jaap
    Letvin, Norman
    Roederer, Mario
    Radosevic, Katarina
    VACCINE, 2012, 30 (41) : 5991 - 5998
  • [8] A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
    Smaill, Fiona
    Jeyanathan, Mangalakumari
    Smieja, Marek
    Medina, Maria Fe
    Thanthrige-Don, Niroshan
    Zganiacz, Anna
    Yin, Cindy
    Heriazon, Armando
    Damjanovic, Daniela
    Puri, Laura
    Hamid, Jemila
    Xie, Feng
    Foley, Ronan
    Bramson, Jonathan
    Gauldie, Jack
    Xing, Zhou
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (205)
  • [9] T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus B19
    Franssila, R
    Hokynar, K
    Hedman, K
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (05): : 805 - 809
  • [10] Mucosal CD8+T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge
    Zheng, Xiaoyan
    Oduro, Jennifer D.
    Boehme, Julia D.
    Borkner, Lisa
    Ebensen, Thomas
    Heise, Ulrike
    Gereke, Marcus
    Pils, Marina C.
    Krmpotic, Astrid
    Guzman, Carlos A.
    Bruder, Dunja
    Cicin-Sain, Luka
    PLOS PATHOGENS, 2019, 15 (09)
12